Cargando…
Polymeric nanoparticles enhance the sonodynamic activity of meso-tetrakis (4-sulfonatophenyl) porphyrin in an in vitro neuroblastoma model
PURPOSE: Sonodynamic therapy is a developing noninvasive modality for cancer treatment, based on the selective activation of a sonosensitizer agent by acoustic cavitation. The activated sonosensitizer agent might generate reactive oxygen species leading to cancer cell death. We investigated the pote...
Autores principales: | , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3826853/ https://www.ncbi.nlm.nih.gov/pubmed/24232189 http://dx.doi.org/10.2147/IJN.S51070 |
_version_ | 1782290969251545088 |
---|---|
author | Canaparo, Roberto Varchi, Greta Ballestri, Marco Foglietta, Federica Sotgiu, Giovanna Guerrini, Andrea Francovich, Andrea Civera, Pierluigi Frairia, Roberto Serpe, Loredana |
author_facet | Canaparo, Roberto Varchi, Greta Ballestri, Marco Foglietta, Federica Sotgiu, Giovanna Guerrini, Andrea Francovich, Andrea Civera, Pierluigi Frairia, Roberto Serpe, Loredana |
author_sort | Canaparo, Roberto |
collection | PubMed |
description | PURPOSE: Sonodynamic therapy is a developing noninvasive modality for cancer treatment, based on the selective activation of a sonosensitizer agent by acoustic cavitation. The activated sonosensitizer agent might generate reactive oxygen species leading to cancer cell death. We investigated the potential poly-methyl methacrylate core-shell nanoparticles (NPs) loaded with meso-tetrakis (4-sulfonatophenyl) porphyrin (TPPS) have to function as an innovative sonosensitizing system, ie, TPPS-NPs. METHODS: Shockwaves (SWs) generated by a piezoelectric device were used to induce acoustic cavitation. The cytotoxic effect of the sonodynamic treatment with TPPS-NPs and SWs was investigated on the human neuroblastoma cell line, SH-SY5Y. Cells were exposed for 12 hours to TPPS-NPs (100 μg/mL) and then to SWs (0.43 mJ/mm(2) for 500 impulses, 4 impulses/second). Treatment with SWs, TPPS, and NPs alone or in combination was carried out as control. RESULTS: There was a statistically significant decrease in SH-SY5Y cell proliferation after the sonodynamic treatment with TPPS-NPs and SWs. Indeed, there was a significant increase in necrotic (16.91% ± 3.89%) and apoptotic (27.45% ± 3.03%) cells at 48 hours. Moreover, a 15-fold increase in reactive oxygen species production for cells exposed to TPPS-NPs and SWs was observed at 1 hour compared with untreated cells. A statistically significant enhanced mRNA (messenger ribonucleic acid) expression of NRF2 (P<0.001) and a significant downregulation of TIGAR (P<0.05) and MAP3K5 (P<0.05) genes was observed in cells exposed to TPPS-NPs and SWs at 24 hours, along with a statistically significant release of cytochrome c (P<0.01) at 48 hours. Lastly, the sonosensitizing system was also investigated in an in vitro three-dimensional model, and the sonodynamic treatment significantly decreased the neuroblastoma spheroid growth. CONCLUSION: The sonosensitizing properties of TPPS were significantly enhanced once loaded onto NPs, thus enhancing the sonodynamic treatment’s efficacy in an in vitro neuroblastoma model. |
format | Online Article Text |
id | pubmed-3826853 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2013 |
publisher | Dove Medical Press |
record_format | MEDLINE/PubMed |
spelling | pubmed-38268532013-11-14 Polymeric nanoparticles enhance the sonodynamic activity of meso-tetrakis (4-sulfonatophenyl) porphyrin in an in vitro neuroblastoma model Canaparo, Roberto Varchi, Greta Ballestri, Marco Foglietta, Federica Sotgiu, Giovanna Guerrini, Andrea Francovich, Andrea Civera, Pierluigi Frairia, Roberto Serpe, Loredana Int J Nanomedicine Original Research PURPOSE: Sonodynamic therapy is a developing noninvasive modality for cancer treatment, based on the selective activation of a sonosensitizer agent by acoustic cavitation. The activated sonosensitizer agent might generate reactive oxygen species leading to cancer cell death. We investigated the potential poly-methyl methacrylate core-shell nanoparticles (NPs) loaded with meso-tetrakis (4-sulfonatophenyl) porphyrin (TPPS) have to function as an innovative sonosensitizing system, ie, TPPS-NPs. METHODS: Shockwaves (SWs) generated by a piezoelectric device were used to induce acoustic cavitation. The cytotoxic effect of the sonodynamic treatment with TPPS-NPs and SWs was investigated on the human neuroblastoma cell line, SH-SY5Y. Cells were exposed for 12 hours to TPPS-NPs (100 μg/mL) and then to SWs (0.43 mJ/mm(2) for 500 impulses, 4 impulses/second). Treatment with SWs, TPPS, and NPs alone or in combination was carried out as control. RESULTS: There was a statistically significant decrease in SH-SY5Y cell proliferation after the sonodynamic treatment with TPPS-NPs and SWs. Indeed, there was a significant increase in necrotic (16.91% ± 3.89%) and apoptotic (27.45% ± 3.03%) cells at 48 hours. Moreover, a 15-fold increase in reactive oxygen species production for cells exposed to TPPS-NPs and SWs was observed at 1 hour compared with untreated cells. A statistically significant enhanced mRNA (messenger ribonucleic acid) expression of NRF2 (P<0.001) and a significant downregulation of TIGAR (P<0.05) and MAP3K5 (P<0.05) genes was observed in cells exposed to TPPS-NPs and SWs at 24 hours, along with a statistically significant release of cytochrome c (P<0.01) at 48 hours. Lastly, the sonosensitizing system was also investigated in an in vitro three-dimensional model, and the sonodynamic treatment significantly decreased the neuroblastoma spheroid growth. CONCLUSION: The sonosensitizing properties of TPPS were significantly enhanced once loaded onto NPs, thus enhancing the sonodynamic treatment’s efficacy in an in vitro neuroblastoma model. Dove Medical Press 2013 2013-11-06 /pmc/articles/PMC3826853/ /pubmed/24232189 http://dx.doi.org/10.2147/IJN.S51070 Text en © 2013 Canaparo et al. This work is published by Dove Medical Press Ltd, and licensed under Creative Commons Attribution – Non Commercial (unported, v3.0) License The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0/. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Ltd, provided the work is properly attributed. |
spellingShingle | Original Research Canaparo, Roberto Varchi, Greta Ballestri, Marco Foglietta, Federica Sotgiu, Giovanna Guerrini, Andrea Francovich, Andrea Civera, Pierluigi Frairia, Roberto Serpe, Loredana Polymeric nanoparticles enhance the sonodynamic activity of meso-tetrakis (4-sulfonatophenyl) porphyrin in an in vitro neuroblastoma model |
title | Polymeric nanoparticles enhance the sonodynamic activity of meso-tetrakis (4-sulfonatophenyl) porphyrin in an in vitro neuroblastoma model |
title_full | Polymeric nanoparticles enhance the sonodynamic activity of meso-tetrakis (4-sulfonatophenyl) porphyrin in an in vitro neuroblastoma model |
title_fullStr | Polymeric nanoparticles enhance the sonodynamic activity of meso-tetrakis (4-sulfonatophenyl) porphyrin in an in vitro neuroblastoma model |
title_full_unstemmed | Polymeric nanoparticles enhance the sonodynamic activity of meso-tetrakis (4-sulfonatophenyl) porphyrin in an in vitro neuroblastoma model |
title_short | Polymeric nanoparticles enhance the sonodynamic activity of meso-tetrakis (4-sulfonatophenyl) porphyrin in an in vitro neuroblastoma model |
title_sort | polymeric nanoparticles enhance the sonodynamic activity of meso-tetrakis (4-sulfonatophenyl) porphyrin in an in vitro neuroblastoma model |
topic | Original Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3826853/ https://www.ncbi.nlm.nih.gov/pubmed/24232189 http://dx.doi.org/10.2147/IJN.S51070 |
work_keys_str_mv | AT canaparoroberto polymericnanoparticlesenhancethesonodynamicactivityofmesotetrakis4sulfonatophenylporphyrininaninvitroneuroblastomamodel AT varchigreta polymericnanoparticlesenhancethesonodynamicactivityofmesotetrakis4sulfonatophenylporphyrininaninvitroneuroblastomamodel AT ballestrimarco polymericnanoparticlesenhancethesonodynamicactivityofmesotetrakis4sulfonatophenylporphyrininaninvitroneuroblastomamodel AT fogliettafederica polymericnanoparticlesenhancethesonodynamicactivityofmesotetrakis4sulfonatophenylporphyrininaninvitroneuroblastomamodel AT sotgiugiovanna polymericnanoparticlesenhancethesonodynamicactivityofmesotetrakis4sulfonatophenylporphyrininaninvitroneuroblastomamodel AT guerriniandrea polymericnanoparticlesenhancethesonodynamicactivityofmesotetrakis4sulfonatophenylporphyrininaninvitroneuroblastomamodel AT francovichandrea polymericnanoparticlesenhancethesonodynamicactivityofmesotetrakis4sulfonatophenylporphyrininaninvitroneuroblastomamodel AT civerapierluigi polymericnanoparticlesenhancethesonodynamicactivityofmesotetrakis4sulfonatophenylporphyrininaninvitroneuroblastomamodel AT frairiaroberto polymericnanoparticlesenhancethesonodynamicactivityofmesotetrakis4sulfonatophenylporphyrininaninvitroneuroblastomamodel AT serpeloredana polymericnanoparticlesenhancethesonodynamicactivityofmesotetrakis4sulfonatophenylporphyrininaninvitroneuroblastomamodel |